The expression, processing and secretion of IL-1 is normally tightly regulated and dysregulation of IL-1 is thought to underlie the chronic progressive inflammation that results in atherosclerosis (leading to stroke and myocardial infarction), type 2 diabetes and osteoarthritis. This evidence concerns the gene IL1B and osteoarthritis.